Related Experiment Video

Updated: Sep 20, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Molecular pathogenesis of thyroid cancer

Dorry L Segev1, Christopher Umbricht, Martha A Zeiger

  • 1Department of Surgery, Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Baltimore, MD 21287, USA.

Surgical Oncology
|August 30, 2003
PubMed

Insights

Molecular changes drive thyroid cancer progression from normal tissue to anaplastic carcinoma. This study evaluates factors in thyroid tumorigenesis, proposing a molecular progression model for follicular thyroid cancers.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Thyroid cancer development involves molecular abnormalities.
  • Progression from normal tissue to anaplastic carcinoma is linked to genetic and cellular changes.
  • Upregulation of growth factors and oncogenes, and downregulation of tumor suppressors are implicated.

Purpose of the Study:

  • To comprehensively evaluate factors involved in thyroid tumorigenesis.
  • To propose a preliminary molecular progression model for thyroid cancer.
  • To provide a framework for integrating future genomic data.

Main Methods:

  • Review and synthesis of existing literature on thyroid cancer molecular pathology.
  • Analysis of molecular alterations associated with thyroid cancer progression stages.
  • Conceptualization of a stepwise molecular model for thyroid tumorigenesis.

Main Results:

  • Thyroid cancer progression involves increased proliferation, decreased apoptosis, disrupted cell adhesion, and immortalization.
  • Evidence suggests an evolutionary molecular process, particularly for follicular thyroid cancers with intermediate phenotypes.
  • Key molecular events include oncogene activation and tumor suppressor inactivation.

Conclusions:

  • A multi-step molecular progression model is proposed for thyroid cancer.
  • This model aids in understanding the evolution of thyroid tumors.
  • The proposed framework facilitates the integration of large-scale genomic findings into thyroid cancer research.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...